Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns

PHASE2RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

March 18, 2026

Study Completion Date

August 29, 2026

Conditions
BurnBurn Wounds - Partial Thickness (2nd Degree)
Interventions
DRUG

KJ101

"1. Clean the wound before applying medication.~2. Apply KJ101 (800U/mL) to the wound.~3. Apply a standard wound dressing after treatment.~4. Apply once daily until complete debridement of necrotic tissue has been achieved. After debridement, apply the medication every other day until the wound closes (maximum treatment duration: 28 days)."

DRUG

Chymotrypsin

"1. Clean the wound before applying medication.~2. Apply Chymotrypsin (800U/mL) to the wound.~3. Apply a standard wound dressing after treatment.~4. Apply once daily until complete debridement of necrotic tissue has been achieved. After debridement, apply the medication every other day until the wound closes (maximum treatment duration: 28 days)."

DRUG

Placebo (Sodium Chloride Injection 0.9%)

"1. Clean the wound before applying medication.~2. Apply Placebo (Sodium Chloride Injection 0.9%) to the wound.~3. Apply a standard wound dressing after treatment.~4. Apply once daily until complete debridement of necrotic tissue has been achieved. After debridement, apply the medication every other day until the wound closes (maximum treatment duration: 28 days)."

Trial Locations (1)

200000

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Bao Pharmaceuticals Co., Ltd.

INDUSTRY

NCT07025408 - Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns | Biotech Hunter | Biotech Hunter